434 results on '"Madge, S."'
Search Results
2. P415 Impact of parenthood on cystic fibrosis (CF) self-care and service implications
3. P313 Knowledge and experiences of fertility, contraception and sexual reproductive health among males with cystic fibrosis in the variant specific therapy era
4. EPS2.01 Recruitment via social media results in systematic differences in responses to survey-based research in cystic fibrosis; but is this always a bad thinğ
5. P416 Routes to parenthood taken by people with cystic fibrosis (pwCF) in the variant specific (VST) era
6. Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study
7. 597 Off-label use of CFTR modulators in the U.K. cystic fibrosis population without a F508del mutation
8. 565 Breastfeeding in cystic fibrosis: a review of nutritional and metabolic impacts
9. WS10.06 How representative are clinical trial cohorts of the general cystic fibrosis population? Implications for trial planning
10. P177 Cystic fibrosis (CF)-related complications and outcomes of women during pregnancy and post-partum in elexacaftor/tezacaftor/ivacaftor (ETI)-era
11. P178 Impact of pre-conception lung function in women with cystic fibrosis (wwCF) on obstetric and neonatal outcomes in the elexacaftor/tezacaftor/ivacaftor (ETI)-era
12. P71 Remote respiratory sampling and unusual Pseudomonas growths in adults with cystic fibrosis: Is there a link?
13. P116 A systematic review to identify and collate the patient-centred factors influencing patient journeys through clinical trials
14. P62 A discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in Cystic Fibrosis (CF) trials
15. 89 A novel cystic fibrosis–pregnancy service: Two-year review after introduction of elexacaftor/tezacaftor/ivacaftor
16. Implementing tablet-based ototoxicity screening in adult respiratory patients
17. WS02.05 The use of elexacaftor/tezacaftor/ivacaftor in adult patients with cystic fibrosis and established liver cirrhosis: a case series
18. ePS5.06 Implementing tablet-based ototoxicity screening in adults with cystic fibrosis
19. ePS6.09 A discrete choice experiment to quantify the influence of trial features on patients’ decisions to join cystic fibrosis clinical trials
20. P046 The effectiveness of CFTR modulators in people with cystic fibrosis and rare mutations – a real-world study
21. P156 Patterns of liver dysfunction and the development of a pathway for liver monitoring in adults with cystic fibrosis (CF) on elexacaftor/tezacaftor/ivacaftor (ETI): a quality improvement project
22. P201 Bowel screening for cancer in pre-transplant people with cystic fibrosis and the accuracy of faecal immunochemical testing
23. Adaptation of hydrophite system for purification of wastewaters of civil aviation enterprises
24. A novel and effective ophthalmology morbidity and mortality meeting
25. 116: Implementing a digital clinic review service in a national lockdown
26. 46: A discrete choice experiment (DCE) to quantify the influence of trial features on the decision to participate in CF trials
27. P157 Severe cystic fibrosis in the CFTR modulator era still exists! The implementation of a novel ‘high risk’ multidisciplinary team approach
28. EPS4.10 Obstetric and neonatal outcomes in women with cystic fibrosis (wwCF) and diabetes in pregnancy
29. WS02.05 Obstetric and neonatal outcomes in cystic fibrosis (CF) show minimal variability with and without elexacaftor/tezacaftor/ivacaftor (ETI)
30. P246 Transition in cystic fibrosis: international trends
31. P075 Are there lessons to be learned from cystic fibrosis patient deaths and the timing of lung transplant referral?
32. P076 Using the Cystic Fibrosis Foundation consensus guidelines to assess the timing of lung transplant referral for individuals with cystic fibrosis in a single large adult UK centre: do they help?
33. P203 Fertile ground: pregnancies in a post-Kaftrio® pandemic era
34. WS14.5 SARS-CoV-2 driving rapid change in cystic fibrosis services: the role of the clinical nurse specialist
35. P051 Rollout of Kaftrio® to adult cystic fibrosis patients at the Royal Brompton Hospital during a global pandemic
36. The outcome of pregnancies in women with cystic fibrosis—single centre experience 1998–2011
37. The existence of a form of cliff swallow Hirundo sp. in Ethiopia
38. Description, moult and measurements of Montifringilla theresae
39. Continued improvements in clinical outcomes in the current ART era: epidemiology of a complete clinic population: P177
40. P057 Assessing the timing and clinical characteristics of patients with cystic fibrosis referred for a lung transplant: an observational single centre study
41. P361 What influences participation in clinical trials by people with cystic fibrosis? A national delphi study
42. ePS1.07 Patient experience of virtual consultations: survey results
43. P045 User experience of virtual consultations
44. Changes in AIDS-defining illnesses in a London clinic, 1987 - 1998
45. Tenofovir-associated renal and bone toxicity
46. PREGNANCY AND DELIVERY IN WOMEN WITH CF: 568
47. AIRWAY CLEARANCE REQUIREMENTS DURING PREGNANCY: 523
48. An audit of viral load in one clinical population to describe features of viraemic patients on antiretroviral therapy
49. No association between HIV disease and its treatment and thyroid function
50. A Comparison of the Prevalence of Urinary Incontinence in Girls With Cystic Fibrosis, Asthma, and Healthy Controls
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.